Aarti Industries commissioned Phase I of its Zone IV project at Jhagadia, Gujarat, marking a significant step in its specialty chemicals expansion strategy. The company commissioned the first phase on September 7, 2026, bringing Calcium Chloride, PEDA and part of its Multipurpose Plant (MPP) into commercial operation. The manufacturing platform strengthens Aarti Industries’ downstream integration and flexible manufacturing capabilities. Moreover, it creates a foundation for commercialising high-value and niche products across several growing end-use markets.
Zone IV Adds New Specialty Chemical Manufacturing Capabilities
Phase I incorporates three key manufacturing components, enabling the company to expand its product portfolio and serve a wider range of applications.
PEDA Expands Downstream Agrochemical Capabilities
PEDA (2-Phenyl Ethyl Diethyl Aniline) extends Aarti Industries’ existing ethylation platform further downstream. The facility builds on the company’s established 2,6-Diethyl Aniline capabilities and supports the development of value-added products for the agrochemical industry.
Calcium Chloride Strengthens Energy and Additives Portfolio
The new Calcium Chloride facility expands Aarti Industries’ Energy & Additives portfolio. The product serves applications across oilfield and energy-related markets, thereby broadening the company’s presence in these sectors.
Multipurpose Plant Enables Flexible Production
The Multipurpose Plant (MPP) provides Aarti Industries with a flexible manufacturing platform for commercialising pilot-validated processes. The facility can help the company scale new chemistries more efficiently while responding faster to changing customer requirements. Its flexible design also allows production across multiple chemical applications.
Zone IV Targets High-Value End-Use Industries
The commissioning of Phase I is expected to support Aarti Industries’ expansion across several
high-value markets.
The new facilities will cater to applications in:
Agrochemicals
Pharmaceuticals
Coatings
Polymers
Energy and additives
Several products planned under the broader Zone IV project are expected to be manufactured in India for the first time, creating additional opportunities for import substitution and domestic value creation.
Flexible Manufacturing Platform to Support Future Growth
According to Suyog Kotecha, Chief Executive Officer, Aarti Industries, the company conceived Zone IV as a flexible manufacturing platform aimed at strengthening integration and expanding its portfolio of niche products. The company plans to progressively commercialise all manufacturing blocks within Zone IV during the current fiscal year. The broader Zone IV platform comprises multiple chemistry blocks designed to support diverse chemical processes. Therefore, it can strengthen the company’s integrated R&D, process development, scale-up and commercial manufacturing ecosystem.
Aarti Industries Strengthens Specialty Chemicals Strategy
The commissioning of Zone IV Phase I represents an important milestone in Aarti Industries’ long-term specialty chemicals strategy. By combining downstream integration, flexible manufacturing and new chemistry platforms, the company is positioning Zone IV to support the development and commercialisation of higher-value products. At the same time, the project can enhance Aarti Industries’ ability to serve customers across multiple industries and respond to evolving global demand. As reported by scan X, Zone IV is expected to become an important building block in the company’s strategy to expand its specialty chemicals portfolio, strengthen manufacturing capabilities and create new high-value growth opportunities.
